Pharmacokinetics of methyldopa in renal failure and bilaterally nephrectomized patients.
暂无分享,去创建一个
E. Myhre | H. Rugstad | E. Arnold | O. Stenbaek | T. Hansen
[1] E. Myhre,et al. Pharmacokinetics of methyldopa in healthy man , 1977, European Journal of Clinical Pharmacology.
[2] D. Greenblatt,et al. Clinical pharmacokinetics (second of two parts). , 1975, The New England journal of medicine.
[3] D. Greenblatt,et al. Drug therapy. Clinical Pharmacokinetics (first of two parts). , 1975 .
[4] E. Myhre,et al. THE EFFECT OF METHYLDOPA ON RENAL FUNCTION IN PATIENTS WITH RENAL INSUFFICIENCY , 1972, Acta medica Scandinavica.
[5] E. Myhre,et al. HYPOTENSIVE EFFECT OF METHYLDOPA IN RENAL FAILURE ASSOCIATED WITH HYPERTENSION , 1972, Acta medica Scandinavica.
[6] E. Myhre,et al. PLASMA TURNOVER OF METHYLDOPA IN ADVANCED RENAL FAILURE , 1972, Acta medica Scandinavica.
[7] J. C. Hunt,et al. Management of hypertension of renal origin. , 1970, The American journal of cardiology.
[8] A. Sjoerdsma,et al. Studies on the Metabolism and Mechanism of Action of Methyldopa , 1963, Circulation.
[9] E. Myhre,et al. The renal excretion of methyldopa. , 1972, Scandinavian journal of clinical and laboratory investigation.